Hanbul Pharm goes bankrupt

Published: 2013-07-29 06:56:00

Updated: 2013-07-29 06:56:00

Hanbul Pharmaceutical, the country’s mid-sized drug maker in terms of sales, was declared bankrupt Wednesday after failing to honor commercial papers, sending out shocking signals to local wholesalers.

The company, founded in 1968, has sustained growth with its ophthalmic drugs and OEM product...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK